Aliases & Classifications for Bronchitis

MalaCards integrated aliases for Bronchitis:

Name: Bronchitis 12 3 44 15 63 73
Chronic Bronchitis 12 76 29 43
Acute Bronchitis 12 43 63 73
Bronchitis, Chronic 76 44 73
Chest Cold 12 3
Acute Lower Respiratory Tract Infection 73
Acute Bronchitis and Bronchiolitis 12
Lower Respiratory Tract Infection 73
Recurrent Wheezy Bronchitis 12
Ci - Chest Infection 12
Bronchitis Chronic 55
Chest Infection 12

Classifications:



Summaries for Bronchitis

MedlinePlus : 43 Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic. Most cases of acute bronchitis get better within several days. But your cough can last for several weeks after the infection is gone. The same viruses that cause colds and the flu often cause acute bronchitis. These viruses spread through the air when people cough, or though physical contact (for example, on unwashed hands). Being exposed to tobacco smoke, air pollution, dusts, vapors, and fumes can also cause acute bronchitis. Less often, bacteria can also cause acute bronchitis. To diagnose acute bronchitis, your health care provider will ask about your symptoms and listen to your breathing. You may also have other tests. Treatments include rest, fluids, and aspirin (for adults) or acetaminophen to treat fever. A humidifier or steam can also help. You may need inhaled medicine to open your airways if you are wheezing. Antibiotics won't help if the cause is viral. You may get antibiotics if the cause is bacterial. NIH: National Heart, Lung, and Blood Institute

MalaCards based summary : Bronchitis, also known as chronic bronchitis, is related to bronchial disease and sinusitis, and has symptoms including cough, shortness of breath and low fever. An important gene associated with Bronchitis is ELANE (Elastase, Neutrophil Expressed), and among its related pathways/superpathways are Innate Immune System and Allograft rejection. The drugs Augmentin and Avelox I.V. have been mentioned in the context of this disorder. Affiliated tissues include lung, testes and skin, and related phenotypes are hematopoietic system and immune system

Disease Ontology : 12 A bronchial disease that is an inflammation of the bronchial tubes. It is caused by bacteria and viruses. The disease has symptom cough with mucus, has symptom shortness of breath, has symptom low fever and has symptom chest tightness.

PubMed Health : 63 About bronchitis: In acute bronchitis, the lower airways (bronchi) are temporarily inflamed. The inflammation is usually caused by cold viruses, so it often occurs together with other symptoms of a cold.Acute bronchitis causes a cough which might not go away for a while, even after the cold has gone away. Although the cough may be unpleasant and persistent, in otherwise healthy people it usually isn’t anything serious. The symptoms then go away on their own after a few weeks. Treatment with medication usually isn’t necessary. Some medications may help relieve the symptoms a bit.

Wikipedia : 76 Bronchitis is inflammation of the bronchi (large and medium-sized airways) in the lungs. Symptoms... more...

Related Diseases for Bronchitis

Diseases related to Bronchitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 346)
# Related Disease Score Top Affiliating Genes
1 bronchial disease 30.7 CCL11 CXCL8 ELANE IL5 RNASE3 TAC1
2 sinusitis 30.7 CFTR CXCL8 IL5 RNASE3
3 pulmonary eosinophilia 30.6 CCL11 IL5 RNASE3
4 chronic eosinophilic pneumonia 30.5 CCL11 IL5 RNASE3
5 status asthmaticus 30.4 CXCL8 ELANE IL5 RNASE3
6 eosinophilic pneumonia 30.4 CCL11 IL5 RNASE3
7 pulmonary emphysema 30.3 ELANE SERPINA1 SERPINB1
8 esophagitis 30.3 CCL11 CXCL8 IL5
9 bronchiolitis obliterans 30.3 CXCL8 MPO TNF
10 acute respiratory distress syndrome 30.3 CXCL8 ELANE TNF
11 gastroesophageal reflux 30.3 CXCL8 IL5 VIP
12 pyelonephritis 30.2 ALB CXCL8 TNF
13 farmer's lung 30.0 CD79A ELANE TNF
14 bronchiectasis 30.0 CFTR CXCL8 ELANE MPO SERPINA1
15 eosinophilic gastroenteritis 30.0 ALB CCL11 IL5 RNASE3
16 common cold 30.0 ALB CCL11 CXCL8 IL5 RNASE3
17 rhinitis 29.9 CCL11 CXCL8 IL5 RNASE3 VIP
18 ostertagiasis 29.6 ALB CD79A
19 maxillary sinusitis 29.5 CD79A MPO RNASE3
20 allergic rhinitis 29.5 CCL11 CXCL8 IL5 MPO RNASE3 VIP
21 pulmonary disease, chronic obstructive 29.4 CCL11 CFTR CXCL8 ELANE MPO RNASE3
22 strongyloidiasis 29.4 CCL11 CD79A IL5
23 protein-losing enteropathy 29.3 ALB CD79A SERPINA1
24 gastroenteritis 29.3 ALB CCL11 CXCL8 IL5 RNASE3 TNF
25 tonsillitis 29.2 CD79A CXCL8 TNF
26 pneumonia 29.2 CCL11 CD40LG CXCL8 ELANE IL5 MPO
27 bronchiolitis 29.2 CCL11 CD40LG CXCL8 IL5 RNASE3 TNF
28 dermatitis, atopic 29.1 CCL11 CXCL8 IL5 RNASE3 TNF VIP
29 bronchopneumonia 29.1 CD40LG CD79A ELANE MPO
30 aspergillosis 29.0 CD79A CFTR ELANE IL5
31 respiratory failure 29.0 ALB CXCL8 ELANE SERPINA1 TNF
32 byssinosis 28.8 CD40LG CD79A SERPINA1
33 glomerulonephritis 28.4 ALB CD40LG CD79A MPO
34 cystic fibrosis 28.3 CFTR CXCL8 ELANE MPO RNASE3 SERPINA1
35 lung disease 27.7 CFTR CXCL8 ELANE IL5 MPO SERPINA1
36 otitis media 27.1 ALB CCL11 CD40LG CD79A CXCL8 RNASE3
37 asthma 25.9 CCL11 CD40LG CD79A CFTR CXCL8 ELANE
38 plastic bronchitis 12.5
39 lung cancer 11.1
40 loeffler endocarditis 10.9 IL5 RNASE3
41 bagassosis 10.9 CXCL8 IL5
42 autoimmune inner ear disease 10.9 MPO TNF
43 pemphigoid gestationis 10.8 CCL11 IL5
44 agammaglobulinemia, x-linked 10.8
45 ciliary dyskinesia, primary, 7 10.8
46 severe combined immunodeficiency 10.8
47 selective igm deficiency disease 10.8
48 chronic laryngitis 10.8
49 pharyngoconjunctival fever 10.8
50 actinobacillosis 10.8

Comorbidity relations with Bronchitis via Phenotypic Disease Network (PDN): (show top 50) (show all 130)


Acquired Polycythemia Active Peptic Ulcer Disease
Acute Conjunctivitis Acute Cor Pulmonale
Acute Cystitis Acute Ethmoiditis
Acute Frontal Sinusitis Acute Kidney Failure
Acute Maxillary Sinusitis Agammaglobulinemia, X-Linked
Allergic Rhinitis Alzheimer Disease
Anthracosis Anxiety
Aortic Valve Disease 1 Asbestosis
Aspergillosis Asthma
Atrophic Gastritis Benign Essential Hypertension
Bronchiectasis Bronchopneumonia
Cardiac Arrest Cerebral Atherosclerosis
Cerebral Degeneration Cerebrovascular Disease
Chronic Ethmoiditis Chronic Frontal Sinusitis
Chronic Kidney Failure Chronic Laryngitis
Chronic Maxillary Sinusitis Chronic Myocardial Ischemia
Chronic Pulmonary Heart Disease Chronic Rhinitis
Conjunctivitis Conn's Syndrome
Cystitis Decubitus Ulcer
Deficiency Anemia Diabetic Polyneuropathy
Diaphragm Disease Duodenitis
Dyskinesia of Esophagus Dysthymic Disorder
Encephalopathy Esophageal Candidiasis
Esophageal Disease Esophagitis
Familial Atrial Fibrillation First-Degree Atrioventricular Block

Graphical network of the top 20 diseases related to Bronchitis:



Diseases related to Bronchitis

Symptoms & Phenotypes for Bronchitis

Symptoms:

12
  • cough
  • shortness of breath
  • low fever
  • chest tightness

UMLS symptoms related to Bronchitis:


coughing, fever, pruritus, snoring, recurrent pharyngitis

MGI Mouse Phenotypes related to Bronchitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 SLPI TMPO TNF CCL11 CD40LG CD79A
2 immune system MP:0005387 9.36 SERPINB1 SLPI TNF VIP CCL11 CD40LG

Drugs & Therapeutics for Bronchitis

PubMedHealth treatment related to Bronchitis: 63

Acute bronchitis gets better on its own without treatment. If you feel weak and ill, it’s best to take it easy for a few days. This also means not doing any sports or other strenuous physical activities. Hot tea or broth is usually considered to have a soothing effect. But there is no scientific proof that drinking a lot more fluids than usual helps, or doesn’t help.Acute bronchitis doesn’t need to be treated with medication. Drugs such as paracetamol (acetaminophen) or ibuprofen are sometimes a good idea, though, for the relief of cold symptoms such as fever and pain.There hasn’t been enough research on the effectiveness of cough medicines that are designed to make you cough less (cough suppressants) or make it easier to cough up phlegm (expectorants). Because coughing has the important function of getting rid of mucus and foreign objects, cough suppressants should only be used for a limited amount of time, and only for really unpleasant, dry coughs that disrupt your sleep. Herbal medicines might relieve coughs somewhat.Because the symptoms are usually caused by viruses, antibiotics don’t help much in the treatment of acute bronchitis. But they can have side effects and contribute to bacteria becoming resistant. So antibiotics aren’t recommended as a treatment for acute bronchitis.

FDA approved drugs:

(show all 6)
# Drug Name Active Ingredient(s) 18 Company Approval Date
1
Augmentin 18 AMOXICILLIN; CLAVULANATE POTASSIUM SmithKline Beecham February 1996
2
Avelox I.V. 18 MOXIFLOXACIN HYDROCHLORIDE Bayer November 2001
3
Biaxin XL 18 CLARITHROMYCIN Abbott Laboratories March 2000
4
Cedax 18 CEFTIBUTEN DIHYDRATE Schering-Plough December 1995
5
Ceftin 18 CEFUROXIME AXETIL GlaxoSmithKline September 1997
6
Tequin 18 Bristol-Myers Squibb December, 1999

Drugs for Bronchitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 366)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83905-01-5 55185 447043
2
Budesonide Approved Phase 4,Phase 2 51333-22-3 63006 5281004
3
Ofloxacin Approved Phase 4,Phase 3,Phase 2,Phase 1 82419-36-1 4583
4
Bambuterol Approved, Investigational Phase 4 81732-65-2, 81732-46-9 54766
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-02-2 5743
6
Etanercept Approved, Investigational Phase 4,Phase 1,Phase 2 185243-69-0
7
Montelukast Approved Phase 4,Phase 3,Phase 2,Not Applicable 158966-92-8 5281040
8
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 51-43-4 5816
9
Terbutaline Approved Phase 4 23031-25-6 5403
10
Acetylcysteine Approved, Investigational Phase 4,Phase 2,Not Applicable 616-91-1 12035
11
Levofloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 100986-85-4 149096
12
Bromhexine Approved Phase 4 3572-43-8
13
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 329-65-7 838
14
Zinc Approved, Investigational Phase 4,Phase 3,Not Applicable 7440-66-6 23994
15
Sulfamethoxazole Approved Phase 4 723-46-6 5329
16
Losartan Approved Phase 4,Not Applicable 114798-26-4 3961
17
Erythromycin Approved, Investigational, Vet_approved Phase 4 114-07-8 12560
18
Mechlorethamine Approved, Investigational Phase 4,Phase 2,Phase 3 51-75-2 4033
19
Doxycycline Approved, Investigational, Vet_approved Phase 4 564-25-0 54671203
20
Telithromycin Approved Phase 4 191114-48-4 5462516 0
21
Clarithromycin Approved Phase 4,Phase 3 81103-11-9 84029
22
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
23
Moxifloxacin Approved, Investigational Phase 4,Phase 3 354812-41-2, 151096-09-2 152946
24
Trimethoprim Approved, Vet_approved Phase 4 738-70-5 5578
25
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
26 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 3 979-32-8
27
Oseltamivir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 204255-11-8, 196618-13-0 65028
28
Prednisolone Approved, Vet_approved Phase 4,Not Applicable 50-24-8 5755
29
Cefuroxime Approved Phase 4,Phase 3 55268-75-2 5361202 5479529
30
Amoxicillin Approved, Vet_approved Phase 4,Phase 3 26787-78-0 33613
31
Norgestimate Approved, Investigational Phase 4,Phase 3 35189-28-7 6540478
32
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3 50-28-2 5757
33
Aztreonam Approved Phase 4 78110-38-0 5362041 5742832
34
Angiotensin II Approved, Investigational Phase 4,Not Applicable 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
35
Methylprednisolone Approved, Vet_approved Phase 4,Not Applicable 83-43-2 6741
36
Ethinyl Estradiol Approved Phase 4,Phase 3 57-63-6 5991
37
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3,Phase 1 53-03-2 5865
38
Fluticasone Approved, Experimental, Investigational Phase 4,Phase 3,Phase 2,Not Applicable 90566-53-3 62924
39
Guaifenesin Approved, Investigational, Vet_approved Phase 4,Phase 3 93-14-1 3516
40
Polyestradiol phosphate Approved Phase 4,Phase 3 28014-46-2
41
Acetazolamide Approved, Vet_approved Phase 4 59-66-5 1986
42
Cefdinir Approved Phase 4 91832-40-5 6915944
43
Acetaminophen Approved Phase 4 103-90-2 1983
44
Ibuprofen Approved Phase 4 15687-27-1 3672
45
Mannitol Approved, Investigational Phase 4 69-65-8 453 6251
46
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 1406-16-2
47
Vitamin D3 Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 67-97-0 6221 5280795
48
Ergocalciferol Approved, Nutraceutical Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 50-14-6 5280793
49
leucovorin Approved, Nutraceutical Phase 4,Phase 1 58-05-9 143 6006
50
Citric Acid Approved, Nutraceutical, Vet_approved Phase 4,Not Applicable 77-92-9 311

Interventional clinical trials:

(show top 50) (show all 668)
# Name Status NCT ID Phase Drugs
1 The Effect of Bronchodilator on Eosinophilic Bronchitis and Cough Variant Asthma Unknown status NCT02002754 Phase 4 Bambuterol Hydrochloride tablets
2 Therapeutic Effect of Different Treatment Course With Inhaled Corticosteroids in Eosinophilic Bronchitis Patients Unknown status NCT02002715 Phase 4 Inhaled budesonide
3 Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis Unknown status NCT01121016 Phase 4 Montelukast
4 Airway Clearance for Prevention of COPD Exacerbation Unknown status NCT00181207 Phase 4
5 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effect of Roflumilast on Endothelial Function in Patients With Chronic Obstructive Pulmonary Disease Unknown status NCT01595750 Phase 4 Roflumilast 500;Placebo
6 Effects of Exercise Training on Systemic Inflammation an Muscle Repair According to the Obstructive Chronic Pulmonary Disease (COPD) Phenotype Unknown status NCT01431625 Phase 4
7 Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS) Unknown status NCT01830959 Phase 4 Roflumilast;Placebo
8 Sunovion Brovana Versus Serevent Inspiratory Capacity High Resolution Computed Tomography Unknown status NCT01361984 Phase 4 Nebulized arformoterol;Salmeterol
9 Small Airways Evaluation and Treatment Unknown status NCT02526758 Phase 4 beclomethasone;formoterol;budesonide
10 Optimizing Influenza Vaccination in Surgical Oncology Patients Unknown status NCT01698177 Phase 4
11 Effect of Vitamin D Supplementation in Young South African Children Hospitalized With Acute Lower Respiratory Infection Unknown status NCT02054182 Phase 4 Vitamin D
12 Home Oxygen Therapy in Bronchiolitis Unknown status NCT01216553 Phase 4
13 Bronchiolitis All-study, SE-Norway Unknown status NCT00817466 Phase 4 Racemic adrenaline;Isotonic saline
14 Moxifloxacin Versus Amoxicillin Clavulanic Acid in Treatment of Acute Exacerbation of Chronic Bronchitis Completed NCT00656747 Phase 4 Avelox (Moxifloxacin, BAY12-8039);Amoxicillin clavulanic acid
15 Mucolytic Effectiveness of Tacholiquine ® in Chronic Bronchitis Completed NCT02515799 Phase 4 Tacholiquine
16 The Effectiveness of Roflumilast in Improving Mucociliary Clearance in Patients With COPD and Chronic Bronchitis Completed NCT03073798 Phase 4 Roflumilast;Placebo
17 Telithromycin: in the Treatment of Acute Exacerbation of Chronic Bronchitis in Adult Outpatients With COPD Completed NCT00538148 Phase 4 Telithromycin
18 PERSPECTIVE: Telithromycin - Acute Exacerbation of Chronic Bronchitis Completed NCT00132938 Phase 4 telithromycin
19 Study of Azithromycin for Lymphocytic Bronchiolitis/Bronchitis After Lung Transplantation Completed NCT01109160 Phase 4 Azithromycin Dihydrate
20 Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) Completed NCT01467297 Phase 4 ceftidoren;levofloxacin
21 Ketek in CAP / AECB in Ambulatory Adult Patients Completed NCT00546676 Phase 4 Telithromycin
22 Efficacy Safety Study of Arformoterol/Tiotropium Combination Versus Either Therapy Alone in Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00424528 Phase 4 Arformoterol Tartrate Inhalation Solution;Tiotropium;Arformoterol and Tiotropium;Placebo
23 Relative Potency of Inhaled Corticosteroids Completed NCT00292838 Phase 4 fluticasone 25, 50, 100, 200 mcg
24 Phase 4 Study - Mucinex D as Adjunct Therapy Completed NCT00441246 Phase 4 Mucinex D (600 mg guaifenesin and 60 mg pseudoephedrine HCl extended-release bi-layer tablets)
25 Effect of Addition Oral Montelukast to Standard Treatment in Acute Asthma in Hospitalized Preschool Children Completed NCT03369119 Phase 4 Montelukast 4 Mg Oral Granule;Placebos
26 Chronic Obstructive Pulmonary Disease (COPD) Post-hospitalization Study Completed NCT01110200 Phase 4 ADVAIR DISKUS 250/50 mg BID;SEREVENT 50 mcg BID
27 Add-on Effects of Tiotropium Over Formoterol in Exercise Tolerance on Chronic Obstructive Pulmonary Disease Patients Completed NCT00680056 Phase 4 Formoterol plus Placebo (Tiotropium);Formoterol plus Tiotropium
28 COPD on Primary Care Treatment (COOPT) Completed NCT00184977 Phase 4 N-acetylcysteine;fluticasone propionate
29 Aizthromycin or Clarithromycin in H-pylori Eradication Regimen Completed NCT01667692 Phase 4 azithromycin;clarithmycin
30 Inhaled Steroid Reduces Systemic Inflammation in COPD Completed NCT00175565 Phase 4 inhaled fluticasone 500 mcg b.i.d.
31 Clinical Trial for the Assessment of Delayed Antibiotic Treatment in Pediatric (DAP-Pediatrics) Completed NCT01800747 Phase 4
32 Roflumilast on Markers of Bone Metabolism and Endothelial Function in COPD Completed NCT01745848 Phase 4 Roflumilast
33 BENEFITS OF ACLIDINIUM BROMIDE IN THE RELIEF OF COPD SYMPTOMS INCLUDING COUGH Completed NCT02375724 Phase 4 Aclidinium Bromide;Placebo
34 Placebo Versus Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00170222 Phase 4 doxycycline
35 Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders Completed NCT00132418 Phase 4 Enbrel;Placebo
36 Efficacy of Losartan in Preventing Progression of COPD Completed NCT00720226 Phase 4 Losartan;Placebo
37 Change of Inspiratory Peak Flow in COPD Completed NCT00561886 Phase 4 Formoterol
38 Advair HFA For Chronic Obstructive Pulmonary Disease(COPD) Completed NCT00633217 Phase 4 Fluticasone Propionate/Salmeterol DISKUS 250/50mcg;Fluticasone Propionate/Salmeterol Hydrofluoroalkane 134a MDI 230/42mcg
39 Telithromycin in Respiratory Tract Infections Completed NCT00261105 Phase 4 telithromycin
40 Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Combinations of Long-acting β2-agonists (LABA) and Inhaled Glucocorticosteroid (ICS) Completed NCT01329029 Phase 4 Roflumilast;Placebo
41 Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations Completed NCT01167452 Phase 4 Sulfamethoxazole/trimethoprim
42 Proteomic Profiling for Influenza Completed NCT00133588 Phase 4
43 Clinical Trial for the Assessment of Delayed Antibiotic Treatment Strategies Completed NCT01363531 Phase 4
44 Effectiveness of Different Exercise Training Programs to the Profile of COPD Patients Completed NCT01336283 Phase 4
45 Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. Completed NCT01694108 Phase 4
46 An Investigation of the Mechanism of Action of Seretide in Chronic Obstructive Pulmonary Disease Completed NCT00974805 Phase 4 Seretide 500 Accuhaler
47 Efficacy of Temporary Positive Expiratory Pressure (TPEP) in Chronic Hypersecretion Completed NCT00700388 Phase 4
48 Efficacy Safety Study of Arformoterol QD Dosing Versus BID Dosing in COPD Completed NCT00571428 Phase 4 Arformoterol Tartrate Inhalation Solution;Arformoterol Tartrate Inhalation Solution;Placebo
49 A 16-Week Study to Evaluate the Effect of Advair DISKUS™ 250/50mcg on Arterial Stiffness in Subjects With Chronic Obstructive Pulmonary Disease (COPD) Completed NCT00857766 Phase 4 ADVAIR DISKUS™ 250/50mcg
50 Study of the Effect of the ROX AC1 on Exercise Capacity and Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients Completed NCT00832611 Phase 4

Search NIH Clinical Center for Bronchitis

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: bronchitis

Genetic Tests for Bronchitis

Genetic tests related to Bronchitis:

# Genetic test Affiliating Genes
1 Chronic Bronchitis 29

Anatomical Context for Bronchitis

MalaCards organs/tissues related to Bronchitis:

41
Lung, Testes, Skin, Heart, Tonsil, Bone, Bone Marrow

Publications for Bronchitis

Articles related to Bronchitis:

(show top 50) (show all 978)
# Title Authors Year
1
Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial. ( 29764875 )
2018
2
Innate antiviral immune response against infectious bronchitis virus and involvement of prostaglandin E2 in the uterine mucosa of laying hens. ( 29407895 )
2018
3
Successful Treatment of Protein-Losing Enteropathy and Plastic Bronchitis by Biphasic Cuirass Ventilation in a Patient with Failing Fontan Circulation. ( 29794380 )
2018
4
Acute phase proteins and stress markers in the immediate response to a combined vaccination against Newcastle disease and infectious bronchitis viruses in specific pathogen free (SPF) layer chicks. ( 29182756 )
2018
5
Exposure to traffic-related air pollution and acute bronchitis in children: season and age as modifiers. ( 29440305 )
2018
6
Perception and Awareness of chronic obstructive pulmonary disease, Chronic Bronchitis and Pulmonary Emphysema in the Spanish Urban Population. ( 29428681 )
2018
7
Non-astmatic Eosinophilic Bronchitis. ( 29404185 )
2018
8
An underestimated cause of chronic cough: The Protracted Bacterial Bronchitis. ( 29387250 )
2018
9
Induction of innate host responses characterized by production of interleukin (IL)-1I^ and recruitment of macrophages to the respiratory tract of chickens following infection with infectious bronchitis virus (IBV). ( 29426399 )
2018
10
Plastic bronchitis associated with adenovirus infection. ( 29582774 )
2018
11
Viral interference between low pathogenic avian influenza H9N2 and avian infectious bronchitis viruses in vitro and in ovo. ( 29940196 )
2018
12
Echocardiographic characteristics in Fontan patients before the onset of protein-losing enteropathy or plastic bronchitis. ( 29082544 )
2018
13
In with acute bronchitis; out with duodenal perforation: the potentially harmful cascade of over-testing. A case report. ( 29441163 )
2018
14
Inappropriate Antibiotic Prescribing for Acute Bronchitis in Children and Impact on Subsequent Episodes of Care and Treatment. ( 29794648 )
2018
15
Induction of innate immune response following introduction of infectious bronchitis virus (IBV) in the trachea and renal tissues of chickens. ( 29330060 )
2018
16
Seroprevalence and genotyping of avian infectious bronchitis virus detected from Iranian unvaccinated backyard chickens. ( 29922421 )
2018
17
Using Multinomial and Space-Time Permutation Models to Understand the Epidemiology of Infectious Bronchitis in California Between 2008 and 2012. ( 29944405 )
2018
18
Rapid development and evaluation of a live-attenuated QX-like infectious bronchitis virus vaccine. ( 29891352 )
2018
19
An adult case of plastic bronchitis: a rare and multifactorial disease. ( 29600096 )
2018
20
Infectious bronchitis virus gel vaccination: evaluation of Mass-like (B-48) and 793/B-like (1/96) vaccine kinetics after combined administration at 1 day of age. ( 29897603 )
2018
21
Exposure to cooking oil fumes and chronic bronchitis in nonsmoking women aged 40A years and over: a health-care based study. ( 29439699 )
2018
22
Protection against Virulent Infectious Bronchitis Virus Challenge Conferred by a Recombinant Baculovirus Co-Expressing S1 and N Proteins. ( 29954092 )
2018
23
Recombinant live attenuated avian coronavirus vaccines with deletions in the accessory genes 3ab and/or 5ab protect against infectious bronchitis in chickens. ( 29366709 )
2018
24
Ambient Air Pollution and Chronic Bronchitis in a Cohort of U.S. Women. ( 29410384 )
2018
25
The ADRP domain from a virulent strain of infectious bronchitis virus is not sufficient to confer a pathogenic phenotype to the attenuated Beaudette strain. ( 29893665 )
2018
26
Gastroesophageal reflux symptoms and nasal symptoms affect the severity of bronchitis symptoms in patients with chronic obstructive pulmonary disease. ( 29773294 )
2018
27
Differential innate immune responses induced by classical and variant infectious bronchitis viruses in specific pathogen free chicks. ( 29751011 )
2018
28
Clinical Outcome of Eosinophilic Airway Inflammation in Chronic Airway Diseases Including Nonasthmatic Eosinophilic Bronchitis. ( 29317659 )
2018
29
Identification of Novel Linear Epitopes Located in the Infectious Bronchitis Virus Spike S2 Region. ( 29944406 )
2018
30
Obstructive bronchitis and recurrent pneumonia in esophageal achalasia in a child: A CARE compliant case report. ( 29879065 )
2018
31
Mitochondrial bioenergy alterations in avian HD11 macrophages infected with infectious bronchitis virus. ( 29302792 )
2018
32
Evaluation of an incidental cardiac finding in a patient with bronchitis. ( 29934369 )
2018
33
Alternative definitions of chronic bronchitis and their correlation with CT parameters. ( 29942122 )
2018
34
Molecular characteristic and pathogenicity analysis of a virulent recombinant avain infectious bronchitis virus isolated in China. ( 29917155 )
2018
35
The clinical, immunological and microbiological impact of the 10-valent pneumococcal-Protein D conjugate vaccine in children with recurrent protracted bacterial bronchitis, chronic suppurative lung disease and bronchiectasis: a multi-centre, double-blind, randomised controlled trial. ( 29944440 )
2018
36
Preparation and protective efficacy of a chicken embryo kidney cell-attenuation GI-19/QX-like avian infectious bronchitis virus vaccine. ( 29859801 )
2018
37
Coexistence of Chronic Bronchitis in Chronic Obstructive Lung Disease. ( 29752708 )
2018
38
Detection of specific bacterial agents by quantitative PCR assays in the bronchoalveolar lavage fluid of dogs with eosinophilic bronchopneumopathy vs. dogs with chronic bronchitis and healthy dogs. ( 29428092 )
2018
39
Assessment of Mycoplasma gallisepticum vaccine efficacy in a co-infection challenge model with QX-like infectious bronchitis virus. ( 29451010 )
2018
40
Management and Treatment of Pediatric Plastic Bronchitis. ( 28238517 )
2017
41
The effect of diatomaceous earth in live, attenuated infectious bronchitis vaccine, immune responses, and protection against challenge. ( 28419351 )
2017
42
Think globally, act locally: Phylodynamic reconstruction of infectious bronchitis virus (IBV) QX genotype (GI-19 lineage) reveals different population dynamics and spreading patterns when evaluated on different epidemiological scales. ( 28880958 )
2017
43
Efficacy of Massachusetts and 793B Vaccines Against Infectious Bronchitis Moroccan-Italy 02 Virus in Specific-Pathogen-Free Chickens and Commercial Broilers. ( 29337615 )
2017
44
Astragalus polysaccharides enhance the immune response to avian infectious bronchitis virus vaccination in chickens. ( 28826771 )
2017
45
Reverse Genetics System for the Avian Coronavirus Infectious Bronchitis Virus. ( 28508215 )
2017
46
Complete genome sequences of two avian infectious bronchitis viruses isolated in Egypt: Evidence for genetic drift and genetic recombination in the circulating viruses. ( 28495648 )
2017
47
Left upper lobe atelectasis due to plastic bronchitis. ( 29276877 )
2017
48
Strategies to Prevent Cast Formation in Patients with Plastic Bronchitis Undergoing Heart Transplantation. ( 28101662 )
2017
49
Different evolutionary trajectories of vaccine-controlled and non-controlled avian infectious bronchitis viruses in commercial poultry. ( 28472110 )
2017
50
Percutaneous thoracic duct intervention to treat plastic bronchitis related to Fontan palliation. ( 28869334 )
2017